The Active Trials metric refers to the count of ongoing trial subscriptions, providing insight into customer engagement and acquisition strategies.
With Databox you can track all your metrics from various data sources in one place.
Used to show a simple Metric or to draw attention to one key number.
Databox is a business analytics software that allows you to track and visualize your most important metrics from any data source in one centralized platform.
To track Active Trials using Databox, follow these steps:
Transactions by Type metric provides a breakdown of transactions by payment type, such as credit card or bank transfer, allowing businesses to analyze payment preferences of their customers.
Churned MRR by Plan Name is a metric that measures the lost revenue from canceled or downgraded subscriptions, segmented by different plan names. It helps to identify which plans have higher or lower churn rates and take actions to reduce churn.
The New Subscriptions (incl. Trials) metric tracks the number of new recurring payments or subscription sign-ups including Trials made by customers in a given period of time.
New Subscriptions (incl. Trials and Inactive Plans) by Plan Name metric measures the number of new subscriptions including Trials, Active Plans, and Inactive Plans created for each plan in a given time frame, providing insights into the performance and popularity of different subscription plans.
New Subscriptions by Plan Name metric measures the number of new subscriptions created for each plan in a given time frame, providing insights into the performance and popularity of different subscription plans.
MRR Upgrades measures the total increase in Monthly Recurring Revenue (MRR) from existing customers who upgraded to a higher-priced subscription plan.
ARR by Plan Name is a metric that calculates the total Annual Recurring Revenue generated by each subscription plan in a given period, providing insights into which plans are driving the most revenue for a business.
Trial Conversion Rate measures success in converting trials to active subscriptions over a rolling 30-day period, excluding today.